A standardized, government-funded gene editing program providing access to a limited set of pre-approved CRISPR therapies targeting common, debilitating genetic diseases. Delivered through state-controlled healthcare systems with strict eligibility criteria and limited customization options. Designed for equitable access at lowest cost.